Creso Pharma Limited Analysis

Creso Pink Sheet Analysis Notes

About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creso Pharma Limited recorded a loss per share of 0.02. The entity had not issued any dividends in recent years. Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia. Creso Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Creso Pharma Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Creso Pharma Limited please contact William BCom at 61 8 9389 3180 or go to https://www.cresopharma.com.

Creso Pharma Limited Investment Alerts

Creso Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Creso Pharma's market, we take the total number of its shares issued and multiply it by Creso Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Creso Profitablity

The company has Profit Margin (PM) of (2.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.39) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.39.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Creso Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Creso shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Creso Pharma. By using and applying Creso Pink Sheet analysis, traders can create a robust methodology for identifying Creso entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.